Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition

OBJECTIVES: This study postulated that antihypertensive therapy with renin-angiotensin-aldosterone system (RAAS) inhibition may mitigate vascular endothelial growth factor inhibitor (VEGFi)–mediated increases in blood pressure more effectively than other antihypertensive medications in patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottinor, Wendy J., Shuey, Megan M., Manouchehri, Ali, Farber-Eger, Eric H., Xu, Meng, Nair, Devika, Salem, Joe-Elie, Wang, Thomas J., Brittain, Evan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513950/
https://www.ncbi.nlm.nih.gov/pubmed/32984850
http://dx.doi.org/10.1016/j.jaccao.2019.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513950/
https://www.ncbi.nlm.nih.gov/pubmed/32984850
http://dx.doi.org/10.1016/j.jaccao.2019.07.002

Ejemplares similares